200,000+ products from a single source!
sales@angenechem.com
96604-21-6 | Methanone, 2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]-
CAS No: 96604-21-6 Catalog No: AG00IJU5 MDL No:MFCD00864695
Product Description
Catalog Number:
AG00IJU5
Chemical Name:
Methanone, 2-pyridinyl[7-(4-pyridinyl)pyrazolo[1,5-a]pyrimidin-3-yl]-
CAS Number:
96604-21-6
Molecular Formula:
C17H11N5O
Molecular Weight:
301.3021
MDL Number:
MFCD00864695
IUPAC Name:
pyridin-2-yl-(7-pyridin-4-ylpyrazolo[1,5-a]pyrimidin-3-yl)methanone
InChI:
InChI=1S/C17H11N5O/c23-16(14-3-1-2-7-19-14)13-11-21-22-15(6-10-20-17(13)22)12-4-8-18-9-5-12/h1-11H
InChI Key:
OQJFBUOFGHPMSR-UHFFFAOYSA-N
SMILES:
O=C(c1cnn2c1nccc2c1ccncc1)c1ccccn1
UNII:
2H6KVC5E76
Properties
Complexity:
425
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
301.096g/mol
Formal Charge:
0
Heavy Atom Count:
23
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
301.309g/mol
Monoisotopic Mass:
301.096g/mol
Rotatable Bond Count:
3
Topological Polar Surface Area:
73A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.5
Literature
| Title | Journal |
|---|---|
| Anxioselective anxiolytics: on a quest for the Holy Grail. | Trends in pharmacological sciences 20121101 |
| Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem. | European journal of pharmacology 20111001 |
| A multicenter, placebo-controlled, double-blind, randomized study of efficacy and safety of ocinaplon (DOV 273,547) in generalized anxiety disorder. | CNS neuroscience & therapeutics 20100401 |
| GABA-A receptor modulators: can they offer any improvement over benzodiazepines in the treatment of anxiety disorders? | CNS neuroscience & therapeutics 20100401 |
| Pharmacological Properties of DOV 315,090, an ocinaplon metabolite. | BMC pharmacology 20080101 |
| Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination. | The Journal of pharmacology and experimental therapeutics 20060301 |
| The benzodiazepine binding site of GABA(A) receptors as a target for the development of novel anxiolytics. | Expert opinion on investigational drugs 20050501 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040101 |
| Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site. | Current drug targets. CNS and neurological disorders 20030801 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030101 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.